Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7834)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 7, 2020 (publication date) through Oct 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang JP, Yao ZG, Sun YW, Liu XH, Sun FK, Lin CH, Ren FX, Lv BB, Zhang SJ, Wang Y, Meng FY, Zheng SZ, Gong W, Liu J. Clinicopathological characteristics and surgical outcomes of sarcomatoid hepatocellular carcinoma. World J Gastroenterol 2020; 26(29): 4327-4342 [PMID: 32848337 DOI: 10.3748/wjg.v26.i29.4327] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i29/4327.htm |
| Number | Citing Articles |
| 1 |
Rao Fu, Fangjing Yu, Weiqi Wu, Juan Liu, Jia Li, Fangyue Guo, Lei Xu, Feng Wang, Xiaonan Cui. Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding. International Immunopharmacology 2021; 101: 108195 doi: 10.1016/j.intimp.2021.108195
|
| 2 |
Xiaoyuan Chen, Yiwei Lu, Xiaoli Shi, Guoyong Han, Long Zhang, Chuangye Ni, Jie Zhao, Yun Gao, Xuehao Wang. Epidemiological and Clinical Characteristics of Five Rare Pathological Subtypes of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864106
|
| 3 |
Wei Ji, Yunlong Xing, Jinshu Ma, Zhuo Zhao, Hongqin Xu, Shuang Zheng, Wei Li, Xu Li. Primary Liver Sarcomatoid Carcinoma: A Case Series and Literature Review. Journal of Hepatocellular Carcinoma 2021; : 1117 doi: 10.2147/JHC.S325182
|
| 4 |
Matthias Pinter, Bernhard Scheiner, David J Pinato. Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice. The Lancet Gastroenterology & Hepatology 2023; 8(8): 760 doi: 10.1016/S2468-1253(23)00147-4
|
| 5 |
Subathra Radhakrishnan, Catherine Ann Martin, Mukul Vij, Komalavalli Subbiah, Lexmi Priya Raju, Gowripriya Gowrishankar, Vidya Harini Veldore, Ilankumaran Kaliamoorthy, Ashwin Rammohan, Mohamed Rela. Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma. Immunotherapy 2024; 16(6): 371 doi: 10.2217/imt-2023-0243
|
| 6 |
Feier Ding, Min Huang, Ping Ren, Junlei Zhang, Zhengyu Lin, Yan Sun, Changhu Liang, Xinya Zhao. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study. European Radiology 2023; 34(4): 2445 doi: 10.1007/s00330-023-10227-9
|
| 7 |
Xiaoling Zhang, Xiaoyu Wang, Liting Jia, Yang Yang, Fan Yang, Shengjun Xiao. CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022; : 57 doi: 10.2147/JHC.S340471
|
| 8 |
Maria G. Fencer, Catherine H. Davis, Jieqi Liu, Mark A. Galan, Kristen R. Spencer. Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 Trial. Journal of Investigative Medicine High Impact Case Reports 2022; 10 doi: 10.1177/23247096221129470
|
| 9 |
Henning Wege, Kornelius Schulze, Johann von Felden, Julien Calderaro, Maria Reig. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. European Journal of Medical Genetics 2021; 64(11): 104313 doi: 10.1016/j.ejmg.2021.104313
|
| 10 |
Guangming He, Weiqing Huang, Zhimei Zhou, Hui Wu, Qin Tian, Lilian Tan, Xi Li. Dynamic contrast-enhanced CT and clinical features of sarcomatoid hepatocellular carcinoma. Abdominal Radiology 2023; 48(10): 3091 doi: 10.1007/s00261-023-03983-1
|
| 11 |
Jingyi Li, Xizhuang Gao, Kun Zhao, Xiangzheng Meng, Shuwei Liu, Jian Zhang. Hepatocellular carcinoma combined with sarcomatoid hepatocellular carcinoma: A case report. Medicine 2024; 103(4): e37013 doi: 10.1097/MD.0000000000037013
|
| 12 |
Tian-Run Lv, Hai-Jie Hu, Parbatraj Regmi, Fei Liu, Fu-Yu Li. Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 2022; 148(7): 1685 doi: 10.1007/s00432-022-03949-8
|
| 13 |
Lintao Chen, Shijian Ruan, Pan Wang, Yongna Cheng, Yubizhuo Wang, Wuwei Tian, Hongbin Zhang, Xiuming Zhang, Wenjie Liang. Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study. Heliyon 2023; 9(3): e14123 doi: 10.1016/j.heliyon.2023.e14123
|
| 14 |
Marcello M. Queiroz, Rodrigo R. Munhoz, Cibele Masotti, Larissa M. Souza, Luiz G.C.A. Lima, Paula F. Asprino, Maria Dirlei F.S. Begnami, Anamaria A. Camargo, Fabiana Bettoni. Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings. JCO Precision Oncology 2022; (6) doi: 10.1200/PO.22.00163
|
| 15 |
Bin Liang, Tao Huang, Shao-Lei Kuang, Guang-Yuan Xie, Tian-Qi Liu, Yuan-Yuan Chen. Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1212013
|
| 16 |
Qiannan Zhao, Zhengbiao Ji, Yanling Chen, Kun Wang, Yijie Qiu, Xiaofan Tian, Yuli Zhu, Hong Qin, Hong Han, Haixia Yuan, Yi Dong, Wenping Wang. Contrast-enhanced ultrasound features of hepatic sarcomatoid carcinoma different from hepatocellular carcinoma. Clinical Hemorheology and Microcirculation 2024; 87(1): 55 doi: 10.3233/CH-231944
|
| 17 |
Yanting Sun, Yun He, Jishuang Tong, Daijiang Liu, Haodong Zhang, Tongchuan He, Yang Bi. All-trans retinoic acid inhibits the malignant behaviors of hepatocarcinoma cells by regulating ferroptosis. Genes & Diseases 2022; 9(6): 1742 doi: 10.1016/j.gendis.2022.04.011
|